Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mercedes Robledo

Showing results (151-160 of 215) with videos related to

Pageof 22
Sort By:
Human Molecular Genetics|February 19, 2013
Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosisIñaki Comino-Méndez, Aguirre A de Cubas, Carmen Bernal, et al.
Endocrine-Related Cancer|October 30, 2023
Regulation of epinephrine biosynthesis in HRAS-mutant paragangliomasMinghao Li, Susan Richter, Hermine Mohr, et al.
The Journal of Clinical Endocrinology and Metabolism|April 2, 2009
Head and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine neoplasia type 2Carsten C Boedeker, Zoran Erlic, Stéphane Richard, et al.
Genes & Diseases|November 11, 2025
Molecular profiling unveils genetic complexity and identifies potential new driver mechanisms in head and neck paragangliomasSara Mellid, Eduardo Caleiras, Ángel M Martínez-Montes, et al.
European Journal of Endocrinology|May 13, 2021
Mass spectrometry imaging identifies metabolic patterns associated with malignant potential in pheochromocytoma and paragangliomaMasanori Murakami, Na Sun, Christian Greunke, et al.
The Journal of Clinical Endocrinology and Metabolism|April 11, 2024
Opposing Effects of Cannabidiol in Patient-derived Neuroendocrine Tumor, Pheochromocytoma/Paraganglioma Primary CulturesKatharina Wang, Laura Schober, Alessa Fischer, et al.
The Lancet. Digital Health|July 20, 2023
Prediction of metastatic pheochromocytoma and paraganglioma: a machine learning modelling study using data from a cross-sectional cohortChristina Pamporaki, Annika M A Berends, Angelos Filippatos, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 14, 2015
Functional and in silico assessment of MAX variants of unknown significanceIñaki Comino-Méndez, Luis J Leandro-García, Guillermo Montoya, et al.
Endocrine|September 18, 2021
Pre- versus post-operative untargeted plasma nuclear magnetic resonance spectroscopy metabolomics of pheochromocytoma and paragangliomaNikolaos G Bliziotis, Leo A J Kluijtmans, Sebastian Soto, et al.
Journal of Medical Genetics|January 31, 2020
Germline mutations in the new E1' cryptic exon of the <i>VHL</i> gene in patients with tumours of von Hippel-Lindau disease spectrum or with paragangliomaAlexandre Buffet, Bruna Calsina, Shahida Flores, et al.
Pageof 22

Showing results (151-160 of 215) with videos related to

Sort By:
Pageof 22
Human Molecular Genetics|February 19, 2013
Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosisIñaki Comino-Méndez, Aguirre A de Cubas, Carmen Bernal, et al.
Endocrine-Related Cancer|October 30, 2023
Regulation of epinephrine biosynthesis in HRAS-mutant paragangliomasMinghao Li, Susan Richter, Hermine Mohr, et al.
The Journal of Clinical Endocrinology and Metabolism|April 2, 2009
Head and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine neoplasia type 2Carsten C Boedeker, Zoran Erlic, Stéphane Richard, et al.
Genes & Diseases|November 11, 2025
Molecular profiling unveils genetic complexity and identifies potential new driver mechanisms in head and neck paragangliomasSara Mellid, Eduardo Caleiras, Ángel M Martínez-Montes, et al.
European Journal of Endocrinology|May 13, 2021
Mass spectrometry imaging identifies metabolic patterns associated with malignant potential in pheochromocytoma and paragangliomaMasanori Murakami, Na Sun, Christian Greunke, et al.
The Journal of Clinical Endocrinology and Metabolism|April 11, 2024
Opposing Effects of Cannabidiol in Patient-derived Neuroendocrine Tumor, Pheochromocytoma/Paraganglioma Primary CulturesKatharina Wang, Laura Schober, Alessa Fischer, et al.
The Lancet. Digital Health|July 20, 2023
Prediction of metastatic pheochromocytoma and paraganglioma: a machine learning modelling study using data from a cross-sectional cohortChristina Pamporaki, Annika M A Berends, Angelos Filippatos, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 14, 2015
Functional and in silico assessment of MAX variants of unknown significanceIñaki Comino-Méndez, Luis J Leandro-García, Guillermo Montoya, et al.
Endocrine|September 18, 2021
Pre- versus post-operative untargeted plasma nuclear magnetic resonance spectroscopy metabolomics of pheochromocytoma and paragangliomaNikolaos G Bliziotis, Leo A J Kluijtmans, Sebastian Soto, et al.
Journal of Medical Genetics|January 31, 2020
Germline mutations in the new E1' cryptic exon of the <i>VHL</i> gene in patients with tumours of von Hippel-Lindau disease spectrum or with paragangliomaAlexandre Buffet, Bruna Calsina, Shahida Flores, et al.
Pageof 22